Company Filing History:
Years Active: 2022
Title: Carina Lotz-Jenne: Innovator in Medicinal Chemistry
Introduction
Carina Lotz-Jenne is a prominent inventor based in Allschwil, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes related to cancer treatment. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Carina Lotz-Jenne holds a patent for "Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase." This invention relates to compounds of Formula (I) that inhibit the enzymes indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO). The patent outlines the synthesis of these compounds and their potential use as medicaments, particularly in the treatment of cancer.
Career Highlights
Carina is currently associated with Idorsia Pharmaceuticals Ltd., where she continues to work on groundbreaking research in the pharmaceutical industry. Her career is marked by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
Throughout her career, Carina has collaborated with notable colleagues, including Christoph Boss and Daniel Bur. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Carina Lotz-Jenne is a remarkable inventor whose work in medicinal chemistry is paving the way for new cancer treatments. Her patent on enzyme inhibitors exemplifies her innovative spirit and dedication to improving healthcare outcomes.